Company Overview
Snapshot
Founded in April 2014 by Yehuda Zadok, Pythagoras Medical operated with 1–10 employees. The company received CE Mark approval for its ConfidenHT System in March 2018, a significant milestone for its medical device technology.
Business overview
Pythagoras Medical developed the ConfidenHT system, a medical device designed to enhance the precision of renal denervation procedures. This technology identifies specific nerves involved in blood pressure regulation, utilizing a multi-electrode catheter and a proprietary algorithm for multifactorial physiological marker analysis. The company operated within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices and Diagnostics Devices markets, serving healthcare providers globally.
Strategic signal
In March 2018, Pythagoras Medical announced that its ConfidenHT System received European CE marking. This regulatory approval was a critical validation for the company's renal denervation technology, indicating its readiness for commercialization in European markets and signaling potential for broader adoption in the medical device industry.
Company Intelligence Q&A
- What is the primary product developed by Pythagoras Medical?
- Pythagoras Medical developed the ConfidenHT system, a mapping system designed to improve the precision of renal denervation procedures by identifying nerves involved in blood pressure regulation.
- When was Pythagoras Medical founded?
- Pythagoras Medical was founded in April 2014.
- What significant regulatory milestone did Pythagoras Medical achieve?
- In March 2018, Pythagoras Medical received European CE Mark approval for its ConfidenHT System, indicating compliance with health, safety, and environmental protection standards for products sold within the European Economic Area.
- Who is a key founder of Pythagoras Medical?
- Yehuda Zadok is a founder of Pythagoras Medical, serving as CEO.
- What is the status of Pythagoras Medical?
- Pythagoras Medical is currently non-active, having ceased operations in July 2019.